<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02834208</url>
  </required_header>
  <id_info>
    <org_study_id>2015-38</org_study_id>
    <secondary_id>2015-A01475-44</secondary_id>
    <nct_id>NCT02834208</nct_id>
  </id_info>
  <brief_title>Emotion Endophenotypes in Schizophrenia</brief_title>
  <acronym>SCHIZOIMAGEN</acronym>
  <official_title>Neurofunctional Basis of Emotion Processing: Clinical, Genetic, Biological and Imaging Study in Patients With Schizophrenia and Healthy Relatives of Patients in Comparison With a Control Group</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Schizophrenia is an invalidating psychiatric illness with a strong genetic component
      characterized by abnormal processing of emotional information. This alteration in emotion
      processing has been described in acute as well as in remission phases of the illness. It has
      also been found in healthy relatives of patients with schizophrenia and in subjects at high
      risk of psychosis. Thus, alterations in emotional information processing are not only linked
      to the prognosis but can also be considered as a marker of vulnerability of schizophrenia. In
      addition, schizophrenia patients differ from healthy controls in neural activity in brain
      regions implicated in emotions processing. However, interpretation of findings in patients is
      limited by confounding factors, such as antipsychotic treatments or alterations due to the
      course of illness. Also, there is no data concerning genetic factors (polymorphisms or gene
      expression) underlying these patterns of cerebral activation in emotion information
      processing.

      So, the main objective of this study is to compare the cerebral activity of schizophrenia
      patients to that of healthy siblings and healthy controls in an emotional processing task.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Oxygen Level dependent (BOLD) signal activity in Anterior Cingulate Cortex (ACC) measured by functional MRI</measure>
    <time_frame>4 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of the functional connectivity in cortico-limbic circuit which underlie the emotional information using functional MRI</measure>
    <time_frame>4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Description of whole brain neuro-anatomy based using Voxel Brain Morphometry (VBM)</measure>
    <time_frame>4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative expression of messenger Ribo Nucleic Acid (mRNA) in Peripheral Blood Mononuclear Cells (PBMC)</measure>
    <time_frame>4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polymorphism (single-nucleotide polymorphism SNP) of DNA (DeoxyriboNucleic Acid)</measure>
    <time_frame>4 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">105</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Schizophrenia subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>35 patients suffering from schizophrenia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy siblings</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>35 healthy siblings of the patients suffering from schizophrenia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>35 healthy &quot;controls &quot;patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI (Magnetic resonance imaging)</intervention_name>
    <arm_group_label>Schizophrenia subjects</arm_group_label>
    <arm_group_label>Healthy siblings</arm_group_label>
    <arm_group_label>Healthy controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Polymorphism (SNP in DNA)</intervention_name>
    <arm_group_label>Schizophrenia subjects</arm_group_label>
    <arm_group_label>Healthy siblings</arm_group_label>
    <arm_group_label>Healthy controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>quantitative measures of mRNA</intervention_name>
    <arm_group_label>Schizophrenia subjects</arm_group_label>
    <arm_group_label>Healthy siblings</arm_group_label>
    <arm_group_label>Healthy controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neuropsychological assessment</intervention_name>
    <arm_group_label>Schizophrenia subjects</arm_group_label>
    <arm_group_label>Healthy siblings</arm_group_label>
    <arm_group_label>Healthy controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female participant, right-handed, aged from 18 to 45 years old

          -  Haven given their written consent

          -  DSM-5 (Diagnostic and Statistical Manual of Mental Disorders version 5) diagnosis of
             schizophrenia

          -  Remitted phase (criteria of Andreasen)

          -  Stable doses of antipsychotics during the last 6 weeks

          -  No severe somatic illness

          -  Normal clinical exam

          -  Inscription to the social security

        Exclusion Criteria:

          -  Women in genitally active period without contraception

          -  Women pregnant or breast feeding

          -  Participants presenting a severe somatic /neurologic condition

          -  Present/history in the last year of alcohol or drug abuse

          -  Participating in another clinical study or still in period of exclusion of a previous
             clinical trial

          -  Contraindication to an MRI test (metallic foreign body, pacemaker, heart valve,
             chirurgical clip, claustrophobia…)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine GEINDRE</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xavier ZENDJIDJIAN, Dr</last_name>
    <phone>04.91.43.50.47</phone>
    <phone_ext>+33</phone_ext>
    <email>xavier.zendjidjian@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pôle Psychiatrie Centre CHU Conception, Marseille, APHM</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier ZENDJIDJIAN, Dr</last_name>
      <phone>04.91.43.50.47</phone>
      <phone_ext>+33</phone_ext>
      <email>xavier.zendjidjian@ap-hm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2016</study_first_submitted>
  <study_first_submitted_qc>July 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2016</study_first_posted>
  <last_update_submitted>August 29, 2016</last_update_submitted>
  <last_update_submitted_qc>August 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

